| 东阳光长江药业 |
BTOA III (Cayman) - NQ GP L.P. |
减持 |
-29592492 |
9557.31万股 |
0.15% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Tactical Opportunities LR Associates (Cayman) – NQ Ltd. |
减持 |
-29592492 |
9557.31万股 |
0.15% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
BTO GP – NQ L.L.C. |
减持 |
-29759891 |
9611.37万股 |
0.15% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Holdings IV L.P. |
减持 |
-29759891 |
9611.37万股 |
0.15% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Holdings IV GP L.P. |
减持 |
-29759891 |
9611.37万股 |
0.15% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Holdings IV GP Management (Delaware) L.P. |
减持 |
-29759891 |
9611.37万股 |
0.15% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Holdings IV GP Limited Partner L.L.C. |
减持 |
-29759891 |
9611.37万股 |
0.15% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Holdings IV GP Management L.L.C. |
减持 |
-29759891 |
9611.37万股 |
0.15% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Inc. |
减持 |
-29759891 |
9611.37万股 |
0.15% |
好仓 |
2023-01-13 |
| 中国同辐 |
Invesco Advisers, Inc. |
减持 |
-2196400 |
221.68万股 |
0.03% |
好仓 |
2023-01-13 |
| 中国同辐 |
Invesco Hong Kong Limited |
减持 |
-838800 |
423.04万股 |
0.05% |
好仓 |
2023-01-13 |
| 金山云 |
The Bank of New York Mellon Corporation |
增持 |
46528890 |
155859.94万股 |
0.41% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Tactical Opportunities Management Associates (Cayman) – NQ L.P. |
减持 |
-29164694 |
9419.14万股 |
0.14% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Holdings IV GP Sub L.P. |
减持 |
-29759891 |
9611.37万股 |
0.15% |
好仓 |
2023-01-13 |
| 东阳光长江药业 |
Blackstone Group Management L.L.C. |
减持 |
-29759891 |
9611.37万股 |
0.15% |
好仓 |
2023-01-13 |
| 法拉帝 |
王仁洁 |
减持 |
-15441768 |
1183.09万股 |
0.04% |
好仓 |
2023-01-13 |
| 法拉帝 |
F Investments S.A. |
减持 |
-15441768 |
1183.09万股 |
0.04% |
好仓 |
2023-01-13 |
| 法拉帝 |
Ferrari Piero |
减持 |
-11830905 |
1544.18万股 |
0.05% |
好仓 |
2023-01-13 |
| 新华制药 |
JPMorgan Chase & Co. |
减持 |
-2662000 |
868.02万股 |
0.04% |
好仓 |
2023-01-13 |
| 鞍钢股份 |
JPMorgan Chase & Co. |
减持 |
-19994197 |
7931.60万股 |
0.06% |
好仓 |
2023-01-13 |
